الفهرس | Only 14 pages are availabe for public view |
Abstract Aim of the work The aim of this study was to evaluate severity of anemia and the difference in response to recombinant human erythropoietin (rhEPO) in diabetic versus non-diabetic patients maintained on regular hemodialysis (CHD) and the possible role of autonomic neuropathy. Conclusion We conclude that the Hb response to EPO is reduced in diabetic patients on hemodialysis. This elevated EPO requirement may be explained by a greater prevalence of infectious diseases, characterized by a significantly higher CRP level, in these patients. Other causes for the elevated EPO requirement may be suggested like autonomic neuropathy and needs further evaluation. |